Surf the 'third wave' of healthcare innovation with Syncona
Life science focused investment trust Syncona (SYNC) generated an excellent net asset value (NAV) total return of 37.9% for the year to 31 March 2019, building on the previous year's impressive 18.7% advance.Following a share price...
11 July 2019